StonvexLoading…
StonvexStonvexStonvexCore line items from XRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.85B | $7.02B | $4.99B | $3.03B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-105.00M | $-1.03B | $-956.00M | $-196.00M |
EPS (Diluted) | $-0.84 | $-8.25 | $-7.67 | $-1.62 |
Total Assets | $9.90B | $9.82B | $10.07B | $8.87B |
Total Liabilities | $9.37B | $9.15B | $9.47B | $7.52B |
Cash & Equivalents | $585.00M | $512.00M | $479.00M | $449.00M |
Free Cash Flow OCF − CapEx | $-156.00M | $187.00M | $-5.00M | $-109.00M |
Shares Outstanding | 130.78M | 128.04M | 128.02M | 125.81M |